These data confirm that NPC1 has a cell autonomous role in microglia and that chronic inflammation which is triggered by its loss is a key feature of NPC neuropathology that should be considered for therapeutic targeting. The gene discussed is NPC1; the disease is nasopharyngeal carcinoma.